New specification for steviol glycoside under evaluation by FSANZ
Australia
Aug 24, 2021
FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.
For further information (in English), click on the Link
Tags:
EFSA's updated guidance on novel food applications
European Union
Sep 30, 2024
EFSA launches call for risk assessment of novel foods and nutrient sources in the EU
European Union
Sep 13, 2024
CONAL discusses new amendments on food labeling and incorporation of novel foods at its 155th meeting
Argentina
Sep 13, 2024
CFSA announces enhanced safety requirements for novel GMO-derived foods
China
Sep 12, 2024
Commission corrects error on Chia seed powders in French version of regulation on novel foods list
European Union
Sep 09, 2024
Vietnam - Protection of Consumer Rights Through Regulation on Insects as Food - Swiss and Belgium Experience for Vietnam
Vietnam
Sep 03, 2024
NHC adds 4 ingredients to the catalogue of substances traditionally considered both foods and Chinese medicines
China
Aug 29, 2024
CFSA reviews three new food ingredients, including peach and lemon leaves
China
Aug 28, 2024
FSANZ to approve D-allulose as a novel food
Australia
Aug 23, 2024
Argentina includes pink rock salt from Pakistan as new food ingredient
Argentina
Aug 22, 2024
NHC approved three new food raw materials
China
Aug 06, 2024
Amendment to specifications for the novel food food 2'-Fucosyllactose derivative strain of Escherichia coli BL-21
European Union
Jul 31, 2024
Commission authorizes Schizochytrium sp. (CABIO-A-2) oil as a novel food
European Union
Jul 31, 2024
Commission authorizes Schizochytrium limacinum (TKD-1) oil as a novel food
European Union
Jul 31, 2024
Amendment to specifications for the novel food protein extract from pig kidneys
European Union
Jul 31, 2024